The ROE as of June 2026 (TTM) for ALK-Abelló A/S (AKABY) is 20.45%

According to ALK-Abelló A/S’s latest financial reports and current stock price. The company's current ROE is 20.45%. This represents a change of 301.72% compared to the average of 5.09% of the last 4 quarters.

ALK-Abelló A/S (AKABY) Historical ROE (quarterly & annually)

How has AKABY ROE performed in the past?

The mean historical ROE of ALK-Abelló A/S over the last ten years is 5.78%. The current 20.45% ROE has changed 253.70% with respect to the historical average. Over the past ten years (40 quarters), AKABY's ROE was at its highest in in the March 2026 quarter at 6.65%. The ROE was at its lowest in in the December 2017 quarter at -4.83%.

ALK-Abelló A/S (AKABY) ROE by Quarter and Year

Discovering the peaks and valleys of ALK-Abelló A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ALK-Abelló A/S (AKABY) Average ROE

How has AKABY ROE performed in the past?

The current ROE of ALK-Abelló A/S (AKABY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ALK-Abelló A/S (AKABY) ROE vs. Peers

How is AKABY’s ROE compared to its peers?

ALK-Abelló A/S’s ROE is less than Abcam plc (0.76%), greater than IVERIC bio, Inc. (-39.26%), greater than Global Blood Therapeutics, Inc. (-98.96%), greater than Alpine Immune Sciences, Inc. (-12.69%), greater than Arena Pharmaceuticals, Inc. (-70.77%), greater than Mirati Therapeutics, Inc. (-61.91%), less than Reata Pharmaceuticals, Inc. (47.21%), less than Churchill Capital Corp XI (0.23%), greater than Turning Point Therapeutics, Inc. (-22.92%), less than RayzeBio, Inc. Common Stock (82.72%),

Build a custom stock screener for ALK-Abelló A/S (AKABY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ALK-Abelló A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ALK-Abelló A/S (AKABY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ALK-Abelló A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.